Twist Bioscience Corp Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q3 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Twist Bioscience Corp quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q3 2018 to Q3 2024.
  • Twist Bioscience Corp Deferred Tax Assets, Net of Valuation Allowance for the quarter ending September 30, 2024 was $18.2M, a 42.8% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $18.2M -$13.7M -42.8% Sep 30, 2024 10-K 2024-11-18
Q3 2023 $31.9M -$1.69M -5.02% Sep 30, 2023 10-K 2024-11-18
Q3 2022 $33.6M +$13.5M +67.6% Sep 30, 2022 10-K 2023-11-21
Q3 2021 $20M +$12.4M +162% Sep 30, 2021 10-K/A 2023-06-05
Q3 2020 $7.65M +$7.52M +5924% Sep 30, 2020 10-K 2021-11-23
Q3 2019 $127K -$56K -30.6% Sep 30, 2019 10-K 2020-11-27
Q3 2018 $183K Sep 30, 2018 10-K 2019-12-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.